UTAH MEDICAL PRODUCTS INC
Net Cash Flow Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Total Cash from Operations: $17.1M
| Line Item | Value | % of Total |
|---|---|---|
| Capital Expenditures | $540.0K | 3.2% |
| Other Investing | $13.6M | 79.5% |
| Dividends Paid | $2.7M | 15.8% |
| Stock Repurchases | $260.6K | 1.5% |
| Net Cash Flow | $0 | 0.0% |